Tentt

SciSparc to Acquire Xylo Endoscope Patent Portfolio

Announced
HealthcareAdd-on

Deal Overview

SciSparc Ltd. has signed a definitive agreement to acquire a portfolio of patents, trademarks, and intellectual property rights for endoscopic systems and medical cameras from Xylo Technologies Ltd., including the MUSE™ system. The MUSE device is a single-use endoscopic platform designed for transoral fundoplication to treat gastroesophageal reflux disease (GERD).

SciSparc plans to begin commercialization immediately after closing. Under the agreement, SciSparc will issue ordinary shares to Xylo at closing that represent 19.99% of SciSparc’s issued and outstanding share capital as of the closing date set for March 8, 2026, with SciSparc able to substitute pre-funded warrants at its discretion. The deal remains subject to customary closing conditions and regulatory approvals.

Key Details

Transaction
SciSparc acquires Xylo Technologies

Source

Read full article on news.google.com

via GN - signs definitive agreement · January 13, 2026

Powered by Tentt

Source healthcare deals for your firm

Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.

Book a 30-min intro call